137080 — Narae NanoTech Balance Sheet
0.000.00%
- KR₩36bn
- KR₩91bn
- KR₩40bn
- 27
- 73
- 17
- 30
Annual balance sheet for Narae NanoTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,769 | 18,960 | 31,565 | 8,400 | 6,904 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 21,305 | 32,742 | 33,857 | 38,344 | 21,740 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 49,036 | 60,523 | 80,732 | 65,213 | 51,080 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 68,031 | 75,151 | 92,567 | 94,578 | 90,691 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 126,947 | 149,522 | 185,445 | 173,053 | 173,432 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 77,719 | 81,823 | 71,950 | 64,216 | 84,542 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 81,027 | 86,948 | 77,476 | 79,499 | 96,987 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 45,921 | 62,574 | 107,969 | 93,554 | 76,445 |
| Total Liabilities & Shareholders' Equity | 126,947 | 149,522 | 185,445 | 173,053 | 173,432 |
| Total Common Shares Outstanding |